Relevance of Nck–CD3ε Interaction for T Cell Activation In Vivo-Reference-Cited by-同舟云学术

Relevance of Nck–CD3ε Interaction for T Cell Activation In Vivo

Published:2014-01-27 Issue:5 Volume:192 Page:2042-2053
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Borroto Aldo,Arellano Irene,Blanco Raquel,Fuentes Manuel,Orfao Alberto,Dopfer Elaine P.,Prouza Marek,Suchànek Miloslav,Schamel Wolfgang W.,Alarcón Balbino

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference38 articles.

1. Wucherpfennig K. W. Gagnon E. Call M. J. Huseby E. S. Call M. E. . 2011. Structural biology of the T-cell receptor: insights into receptor assembly, ligand recognition, and initiation of signaling. Cold Spring Harb. Perspect. Biol. 2: a005140.

2. Love P. E. Hayes S. M. . 2010. ITAM-mediated signaling by the T-cell antigen receptor. Cold Spring Harb. Perspect. Biol. 2: a002485.

3. Tyrosine Phosphorylation of the CD3-ε Subunit of the T Cell Antigen Receptor Mediates Enhanced Association with Phosphatidylinositol 3-Kinase in Jurkat T Cells

4. DeFord-Watts L. M. Young J. A. Pitcher L. A. van Oers N. S. . 2007. The membrane-proximal portion of CD3 epsilon associates with the serine/threonine kinase GRK2. J. Biol. Chem. 282: 16126–16134.

5. Delgado, P., B. Cubelos, E. Calleja, N. Martinez-Martin, A. Cipres, I. Merida, C. Bellas, X. R. Bustelo, and B. Alarcon. 2009. Essential function for the GTPase TC21 in homeostatic antigen receptor signaling. Nat. Immunol. 10: 880–888.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion;Cell;2024-04

2. A survey of the adaptive immune genes of the polka-dot batfish Ogcocephalus cubifrons;BMC Immunology;2023-07-21

3. Charging CAR by electrostatic power;Immunological Reviews;2023-06-27

4. Regulation and function of poised mRNAs in lymphocytes;BioEssays;2023-04-03

5. Modulating T Cell Responses by Targeting CD3;Cancers;2023-02-13